GRI Bio (GRI) Shares Outstanding (2020 - 2026)
GRI Bio (GRI) posted quarterly Shares Outstanding (Entity) of $1.2 million for Q1 2026, up 6514.79% year-over-year from $18761.0 in Q1 2025, and up 1164.24% quarter-over-quarter from $98162.0 in Q4 2025.
GRI Bio (GRI) Shares Outstanding (2020 - 2026) Analysis & Trends
GRI Bio's Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 6514.79% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (up 6514.79% YoY), while the FY2025 annual figure was $98162.0, up 1399.8% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $1.2 million, up from $98162.0 in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $1.2 million in Q1 2026, with the low at $5.0 in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $667.0 (2024), against an average of $91516.4.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) increased 25.0% in 2022, then jumped 9177.94% in 2025.
- GRI Bio's Shares Outstanding (Entity) stood at $8.0 in 2022, then soared by 837.5% to $75.0 in 2023, then soared by 8626.67% to $6545.0 in 2024, then surged by 1399.8% to $98162.0 in 2025, then soared by 1164.24% to $1.2 million in 2026.
- Business Quant data shows GRI's Shares Outstanding (Entity) at $1.2 million in Q1 2026, $98162.0 in Q4 2025, and $93614.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | GRI Bio | 3.01 Mn | 3.01 Mn | - | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.24 Mn |
| Dec 31, 2025 | 98,162.00 |
| Sep 30, 2025 | 93,614.00 |
| Jun 30, 2025 | 78,746.00 |
| Mar 31, 2025 | 18,764.00 |
| Dec 31, 2024 | 6,545.00 |
| Sep 30, 2024 | 6,639.00 |
| Jun 30, 2024 | 961.00 |
| Mar 31, 2024 | 667.00 |
| Dec 31, 2023 | 75.00 |
| Sep 30, 2023 | 95.00 |
| Jun 30, 2023 | 56.00 |
| Mar 31, 2023 | 10.00 |
| Dec 31, 2022 | 8.00 |
| Sep 30, 2022 | 9.00 |
| Jun 30, 2022 | 7.00 |
| Mar 31, 2022 | 5.00 |
| Dec 31, 2021 | 5.00 |
| Sep 30, 2021 | 5.00 |
| Jun 30, 2021 | 5.00 |